
Opinion|Videos|June 24, 2024
Using Fusion-Guided Biopsy to Determine Eligibility for Focal Therapy
The panel discusses how fusion-guided biopsy can inform patient eligibility for focal therapy in prostate cancer.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- What is the role of fusion-guided biopsy in determining patient eligibility for focal therapy?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5















